首页 | 本学科首页   官方微博 | 高级检索  
检索        

米非司酮诱导雄激素非依赖性前列腺癌细胞凋亡的实验研究
引用本文:Zhang H,Lü JJ,Gao QZ,Zhang J.米非司酮诱导雄激素非依赖性前列腺癌细胞凋亡的实验研究[J].中华外科杂志,2006,44(6):382-385.
作者姓名:Zhang H  Lü JJ  Gao QZ  Zhang J
作者单位:1. 250021,济南,山东大学山东省立医院泌尿外科
2. 250021,济南,山东大学山东省立医院中心实验室
基金项目:国家自然基金资助项目(30471731)
摘    要:目的探讨米非司酮在体外诱导雄激素非依赖性前列腺癌DU-145、PC-3细胞凋亡的作用。方法采用四甲基偶氮唑蓝法检测1,10,50和100μmol/L米非司酮作用于前列腺癌DU-145、PC-3细胞24~120h的吸光度(A)值,用流式细胞仪检测10μmol/L米非司酮作用24和48h后DU.145、PC-3细胞凋亡率的变化;采用免疫组化法检测米非司酮作用DU-145、PC.3细胞后bax、bcl-2、血管内皮生长因子(VEGF)蛋白表达的变化。结果1μmol/L米非司酮组的A值与对照组相比,差异无统计学意义(P〉0.05);10,50和100μmol/L米非司酮组的A值与对照组比较,差异有统计学意义(P〈0.01);米非司酮对前列腺癌DU-145、PC-3细胞的抑制作用呈时间-剂量依赖性。10μmol/L米非司酮作用前列腺癌DU-145细胞24和48h的凋亡率分别为15.3%和30.4%,PC-3细胞的凋亡率分别为22.2%和32.0%。经10μmol/L米非司酮作用后,DU-145、PC-3细胞中VEGF和bcl-2蛋白的表达明显减少,而bax的表达显著增加(P〈0.05)。结论米非司酮以时间.剂量依赖性方式抑制激素非依赖性前列腺癌DU-145和Pc-3细胞的增殖,其作用可能是通过降低VEGF蛋白的表达。从而下调bcl-2、激活bax蛋白的表达来实现。

关 键 词:米非司酮  前列腺肿瘤  脱噬作用
收稿时间:2005-08-11
修稿时间:2005-08-11

Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro
Zhang Hui,Lü Jia-ju,Gao Qing-zhen,Zhang Jie.Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro[J].Chinese Journal of Surgery,2006,44(6):382-385.
Authors:Zhang Hui  Lü Jia-ju  Gao Qing-zhen  Zhang Jie
Institution:Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China
Abstract:OBJECTIVE: To investigate the effects of mifepristone on cell proliferation of human androgen-independent prostate carcinoma cell lines DU-145, PC-3 in vitro and the possible mechanisms involved. METHODS: The A values of the prostate cancer cells DU-145 and PC-3 in each group with various concentrations (1, 10, 50, 100 micromol/L) of mifepristone at various time intervals (24-120 h) were detected with the colorimetric 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl tetrazolium bromide assay. The apoptosis rates of the DU-145 and PC-3 cells treated with 10 micromol/L of mifepristone for 24 h and 48 h were assessed by flow cytometry analysis technique. Immunohistochemical technique was used to determine the expression of bax, bcl-2 and vascular endothelial growth factor (VEGF) proteins after treatment with 10 micromol/L of mifepristone. RESULTS: The A values of the cancer cells treated with 1 micromol/L of mifepristone were similar to that of controls, while those of the cells treated with 10 micromol/L, 50 micromol/L and 100 micromol/L of mifepristone were significantly different from that of controls (P < 0.01). Mifepristone markedly inhibited cell proliferation of prostate cancer cells DU-145 and PC-3 on a dose- and time-depending manner. The apoptosis rates of 10 micromol/L mifepristone for DU-145 cell line at 24 h, 48 h were respectively 15.3%, 30.4% with flow cytometry method and then PC-3 cell line were respectively 22.2%, 32.0%. Immunohistochemical technique showed the expression of bcl-2 and VEGF in the DU-145 and PC-3 cells treated with 10 micromol/L of mifepristone were significantly decreased, and the expression of bax was increased. CONCLUSIONS: Mifepristone can induce apoptosis of androgen-independent prostate cancer cell lines DU-145 and PC-3 in vitro. The apoptosis effect is time-and-dose dependent. Mifepristone could initiate a cell death command via apoptotic pathways decreasing the expression of VEGF protein, downregulating the expression of bcl-2 protein and increasing the expression of bax protein.
Keywords:Mifepristone  Prostatic neoplasma  Apoptosis
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号